vTv Therapeutics (NASDAQ:VTVT) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a research note issued to investors on Tuesday. The firm issued a sell rating on the biotechnology company’s ...
Checkpoint Therapeutics’ (CKPT) Hold Rating Reaffirmed at Lake Street Capital
Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report)‘s stock had its “hold” rating reiterated by equities research ...